Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients

View source ↗

Summary

A national screening program is being developed to detect islet autoantibodies in first-degree relatives of people with Type 1 diabetes mellitus, sponsored by R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rabin Medical Center | Conditions: Type 1 Diabetes, Autoantibodies Screening | Status: RECRUITING